Our research focuses on understanding the bidirectional exercise-drug interactions and addiction-related behaviours. Through rigorous experimental protocols and international collaborations, we contribute to advancing exercise science and clinical pharmacology, from molecular mechanisms to translational interventions aimed at improving public health and optimizing therapeutic outcomes.